XML 13 R4.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Operations - USD ($)
3 Months Ended
Feb. 29, 2016
Feb. 28, 2015
Income Statement [Abstract]    
Revenues $ 279,380 $ 894
Cost and expenses:    
Costs of goods sold 191,209 626
Selling, general and administrative 304,151 67,318
Total costs and expenses 495,360 67,944
Loss from operations (215,980) (67,050)
Other income (expense):    
Interest expense (163,149) (354,767)
Amortization of deferred finance costs (171,829) (5,305)
Gain on troubled debt restructuring 527,469
Loss on abandonment/theft of assets (81,466)
Impairment of investment (176,000)
Gain on settlement of derivative liabilities 115,953
Gain (loss) on change in value of derivative liabilities 558,919 (2,169,741)
Total other income (33,525) (1,886,391)
Net income (loss) (249,505) (1,953,441)
Net loss attributable to noncontrolling interest 118,821
Net income (loss) attributable to Pervasip Corp. (130,684) (1,953,441)
Accretion of preferred stock dividends 5,324 36,541
Net income (loss) attributable to common stockholders $ (136,008) $ (1,989,982)
Basic earnings per share $ (0.00) $ (0.00)
Diluted earnings per share $ (0.00) $ (0.00)
Weighted average number of shares outstanding: Basic 3,652,005,709 1,666,509,278
Weighted average number of shares outstanding: Diluted 3,652,005,709 1,666,509,278